Price · 10 years
Click the price chart to set a price alert
Arcutis Biotherapeutics, Inc.
NASDAQ · EQUITY
Click the price chart to set a price alert
Click the RSI chart to set an RSI alert
In the last 12 months, 1 member of Congress disclosed buying ARQT, most recently Gil Cisneros (trade on May 29, 2026, disclosed Jun 8, 2026).
| Traded | Member | Action | Amount | Disclosed |
|---|---|---|---|---|
| May 29, 2026 | Gil Cisneros CA31 | Bought shares | $1K–$15K | Jun 8, 2026 |
| Mar 3, 2026 | Gil Cisneros CA31 | Bought shares | $1K–$15K | Apr 7, 2026 |
| Dec 11, 2025 | Gil Cisneros CA31 | Sold some shares | $1K–$15K | Jan 12, 2026 |
Email Me When a Member of Congress Discloses a Trade in ARQT
What subscribers were emailed
Subscribers were emailed this on Jun 8, 2026.
From House and Senate members' STOCK Act disclosures. See which members pick the best stocks on the Congress stock trading leaderboard.
How much of each tracked fund's portfolio is in ARQT, from their latest 13F filings.
Loading fund ownership…
Revenue, margins, earnings, and cash flow for ARQT, from SEC filings.
Loading financials…
A fair-value estimate for ARQT you can set a price alert against.
Valuation is built on the same fundamentals feed as the Financials tab. Once it lands, the plan is to let you alert on the gap between price and fair value — not just on a price level.
Decision-first research for ARQT, with the full supporting analysis.
No research reports for ARQT yet.
Form 4/5 buys, sells, and grants reported by ARQT officers and directors.
Loading insider activity…
Arcutis Biotherapeutics, Inc. (ARQT) has a live price chart, RSI(14), moving averages, and volume. Click the chart to set an email alert when price or RSI hits a level.
Private to you. Saved automatically as you type.
Sign up to keep notes on ARQT.